Bayer to buy AskBio for $2B in bid to become gene therapy player
Novartis' most advanced kidney compound shows promise in C3G
JNJ and AZ COVID vaccine trials resuming
Inside Rudy Giuliani's track record as a pharma consultant
*please scroll down for all the latest news*